BACKGROUND: The primary aim of the disease management program (DMP) for patients with asthma is to improve health outcomes and to reduce costs. Five years after its introduction in Germany, no consensus has yet been reached as to whether DMP has been effective in reaching these goals. OBJECTIVE: To evaluate the DMP for asthma in Bavaria using routinely collected subject medical records. METHODS: A longitudinal population-based study encompassing over 100,000 DMP participants between 2006 (when the program began) and 2010. RESULTS: The prescription rate of oral corticosteroids dropped from 15.7% in 2006 to 13.6% in 2007, and again from 7.5% in 2008 to 5.9% in 2010 (P < .001). The proportion of subjects with asthma self-management education increased from 4.4% to 23.4% (P < .001). Utilization of an individual asthma action plan increased from 40.3% to 69.3% (P < .001). Hospitalization decreased from 2.8% to 0.7% (P < .001). CONCLUSIONS: In the first 4 years of DMP there was an improvement in pharmacotherapy and patient self management. The proportion of subjects requiring hospitalization decreased. Our results suggest that the German DMP for asthma has been effective in enhancing the quality of care in regard to an improved symptom frequency, adherence to guidelines, pharmacotherapy, and hospitalization.
BACKGROUND: The primary aim of the disease management program (DMP) for patients with asthma is to improve health outcomes and to reduce costs. Five years after its introduction in Germany, no consensus has yet been reached as to whether DMP has been effective in reaching these goals. OBJECTIVE: To evaluate the DMP for asthma in Bavaria using routinely collected subject medical records. METHODS: A longitudinal population-based study encompassing over 100,000 DMPparticipants between 2006 (when the program began) and 2010. RESULTS: The prescription rate of oral corticosteroids dropped from 15.7% in 2006 to 13.6% in 2007, and again from 7.5% in 2008 to 5.9% in 2010 (P < .001). The proportion of subjects with asthma self-management education increased from 4.4% to 23.4% (P < .001). Utilization of an individual asthma action plan increased from 40.3% to 69.3% (P < .001). Hospitalization decreased from 2.8% to 0.7% (P < .001). CONCLUSIONS: In the first 4 years of DMP there was an improvement in pharmacotherapy and patient self management. The proportion of subjects requiring hospitalization decreased. Our results suggest that the German DMP for asthma has been effective in enhancing the quality of care in regard to an improved symptom frequency, adherence to guidelines, pharmacotherapy, and hospitalization.
Authors: Benedikt Kohler; Christina Kellerer; Konrad Schultz; Michael Wittmann; Oxana Atmann; Klaus Linde; Alexander Hapfelmeier; Antonius Schneider Journal: Dtsch Arztebl Int Date: 2020 Impact factor: 5.594
Authors: Marietta Rottenkolber; Rainald Fischer; Luisa Ibáñez; Joan Fortuny; Robert Reynolds; Justyna Amelio; Roman Gerlach; Martin Tauscher; Petra Thürmann; Joerg Hasford; Sven Schmiedl Journal: BMC Pulm Med Date: 2015-05-06 Impact factor: 3.317
Authors: Bernardino Alcazar; Pilar de Lucas; Joan B Soriano; Alonso Fernández-Nistal; Antonia Fuster; Jose Miguel Rodríguez González-Moro; Aurelio Arnedillo; Patricia García Sidro; María José Espinosa de Los Monteros Journal: BMC Pulm Med Date: 2016-11-08 Impact factor: 3.317
Authors: Monica J Fletcher; Ioanna Tsiligianni; Janwillem W H Kocks; Andrew Cave; Chi Chunhua; Jaime Correia de Sousa; Miguel Román-Rodríguez; Mike Thomas; Peter Kardos; Carol Stonham; Ee Ming Khoo; David Leather; Thys van der Molen Journal: NPJ Prim Care Respir Med Date: 2020-06-17 Impact factor: 2.871